Aytu BioPharma AYTU Stock
Aytu BioPharma Price Chart
Aytu BioPharma AYTU Financial and Trading Overview
| Aytu BioPharma stock price | 2.89 USD |
| Previous Close | 1.75 USD |
| Open | 1.75 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 1.65 - 1.85 USD |
| 52 Week Range | 1.4 - 16.2 USD |
| Volume | 57.58K USD |
| Avg. Volume | 83.39K USD |
| Market Cap | 6.99M USD |
| Beta (5Y Monthly) | -0.403237 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 120 USD |
AYTU Valuation Measures
| Enterprise Value | 11.96M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.245614 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.06716185 |
| Price/Book (mrq) | 0.1709007 |
| Enterprise Value/Revenue | 0.115 |
| Enterprise Value/EBITDA | -0.905 |
Trading Information
Aytu BioPharma Stock Price History
| Beta (5Y Monthly) | -0.403237 |
| 52-Week Change | -81.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 16.2 USD |
| 52 Week Low | 1.4 USD |
| 50-Day Moving Average | 2.01 USD |
| 200-Day Moving Average | 3.1 USD |
AYTU Share Statistics
| Avg. Volume (3 month) | 83.39K USD |
| Avg. Daily Volume (10-Days) | 73.94K USD |
| Shares Outstanding | 3.78M |
| Float | 3.34M |
| Short Ratio | 6.42 |
| % Held by Insiders | 4.19% |
| % Held by Institutions | 11.91% |
| Shares Short | 596.8K |
| Short % of Float | 16.50% |
| Short % of Shares Outstanding | 15.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -30.80% |
| Operating Margin (ttm) | -21.36% |
| Gross Margin | 60.42% |
| EBITDA Margin | -12.69% |
Management Effectiveness
| Return on Assets (ttm) | -8.79% |
| Return on Equity (ttm) | -62.86% |
Income Statement
| Revenue (ttm) | 104.12M USD |
| Revenue Per Share (ttm) | 37.54 USD |
| Quarterly Revenue Growth (yoy) | -6.099% |
| Gross Profit (ttm) | 52.28M USD |
| EBITDA | -13218000 USD |
| Net Income Avi to Common (ttm) | -32077000 USD |
| Diluted EPS (ttm) | -11.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 19.18M USD |
| Total Cash Per Share (mrq) | 5.07 USD |
| Total Debt (mrq) | 25.09M USD |
| Total Debt/Equity (mrq) | 61.34 USD |
| Current Ratio (mrq) | 0.919 |
| Book Value Per Share (mrq) | 10.825 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21589000 USD |
| Levered Free Cash Flow (ttm) | -11423500 USD |
Profile of Aytu BioPharma
| Country | United States |
| State | CO |
| City | Englewood |
| Address | 373 Inverness Parkway |
| ZIP | 80112 |
| Phone | 855-298-8246 |
| Website | https://aytubio.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 164 |
Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.
Q&A For Aytu BioPharma Stock
What is a current AYTU stock price?
Aytu BioPharma AYTU stock price today per share is 2.89 USD.
How to purchase Aytu BioPharma stock?
You can buy AYTU shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aytu BioPharma?
The stock symbol or ticker of Aytu BioPharma is AYTU.
Which industry does the Aytu BioPharma company belong to?
The Aytu BioPharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does Aytu BioPharma have in circulation?
The max supply of Aytu BioPharma shares is 5.57M.
What is Aytu BioPharma Price to Earnings Ratio (PE Ratio)?
Aytu BioPharma PE Ratio is now.
What was Aytu BioPharma earnings per share over the trailing 12 months (TTM)?
Aytu BioPharma EPS is -4.01 USD over the trailing 12 months.
Which sector does the Aytu BioPharma company belong to?
The Aytu BioPharma sector is Healthcare.
Aytu BioPharma AYTU included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}